Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
Identifieur interne : 000167 ( PubMed/Corpus ); précédent : 000166; suivant : 000168Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
Auteurs : Tobias Boettler ; Philip N. Newsome ; Mario U. Mondelli ; Mojca Maticic ; Elisa Cordero ; Markus Cornberg ; Thomas BergSource :
- JHEP reports : innovation in hepatology [ 2589-5559 ] ; 2020.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.
DOI: 10.1016/j.jhepr.2020.100113
PubMed: 32289115
Links to Exploration step
pubmed:32289115Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.</title><author><name sortKey="Boettler, Tobias" sort="Boettler, Tobias" uniqKey="Boettler T" first="Tobias" last="Boettler">Tobias Boettler</name><affiliation><nlm:affiliation>Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Newsome, Philip N" sort="Newsome, Philip N" uniqKey="Newsome P" first="Philip N" last="Newsome">Philip N. Newsome</name><affiliation><nlm:affiliation>National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Mondelli, Mario U" sort="Mondelli, Mario U" uniqKey="Mondelli M" first="Mario U" last="Mondelli">Mario U. Mondelli</name><affiliation><nlm:affiliation>Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Maticic, Mojca" sort="Maticic, Mojca" uniqKey="Maticic M" first="Mojca" last="Maticic">Mojca Maticic</name><affiliation><nlm:affiliation>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Slovenia.</nlm:affiliation></affiliation></author><author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name><affiliation><nlm:affiliation>Department of Medicine, University of Seville, Clinical Unit of Infectious Diseases University Hospital Virgen del Rocio, Institute of Biomedicine, Sevilla, CSIC, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Cornberg, Markus" sort="Cornberg, Markus" uniqKey="Cornberg M" first="Markus" last="Cornberg">Markus Cornberg</name><affiliation><nlm:affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Berg, Thomas" sort="Berg, Thomas" uniqKey="Berg T" first="Thomas" last="Berg">Thomas Berg</name><affiliation><nlm:affiliation>Division of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectious Diseases, and Pneumology, University Hospital Leipzig, Leipzig, Germany.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32289115</idno><idno type="pmid">32289115</idno><idno type="doi">10.1016/j.jhepr.2020.100113</idno><idno type="wicri:Area/PubMed/Corpus">000167</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000167</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.</title><author><name sortKey="Boettler, Tobias" sort="Boettler, Tobias" uniqKey="Boettler T" first="Tobias" last="Boettler">Tobias Boettler</name><affiliation><nlm:affiliation>Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Newsome, Philip N" sort="Newsome, Philip N" uniqKey="Newsome P" first="Philip N" last="Newsome">Philip N. Newsome</name><affiliation><nlm:affiliation>National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Mondelli, Mario U" sort="Mondelli, Mario U" uniqKey="Mondelli M" first="Mario U" last="Mondelli">Mario U. Mondelli</name><affiliation><nlm:affiliation>Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Maticic, Mojca" sort="Maticic, Mojca" uniqKey="Maticic M" first="Mojca" last="Maticic">Mojca Maticic</name><affiliation><nlm:affiliation>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Slovenia.</nlm:affiliation></affiliation></author><author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name><affiliation><nlm:affiliation>Department of Medicine, University of Seville, Clinical Unit of Infectious Diseases University Hospital Virgen del Rocio, Institute of Biomedicine, Sevilla, CSIC, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Cornberg, Markus" sort="Cornberg, Markus" uniqKey="Cornberg M" first="Markus" last="Cornberg">Markus Cornberg</name><affiliation><nlm:affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Berg, Thomas" sort="Berg, Thomas" uniqKey="Berg T" first="Thomas" last="Berg">Thomas Berg</name><affiliation><nlm:affiliation>Division of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectious Diseases, and Pneumology, University Hospital Leipzig, Leipzig, Germany.</nlm:affiliation></affiliation></author></analytic><series><title level="j">JHEP reports : innovation in hepatology</title><idno type="eISSN">2589-5559</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32289115</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5559</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JHEP reports : innovation in hepatology</Title><ISOAbbreviation>JHEP Rep</ISOAbbreviation></Journal><ArticleTitle>Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.</ArticleTitle><Pagination><MedlinePgn>100113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhepr.2020.100113</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.</AbstractText><CopyrightInformation>© 2020 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boettler</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newsome</LastName><ForeName>Philip N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mondelli</LastName><ForeName>Mario U</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maticic</LastName><ForeName>Mojca</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordero</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Seville, Clinical Unit of Infectious Diseases University Hospital Virgen del Rocio, Institute of Biomedicine, Sevilla, CSIC, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornberg</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Individualised Infection Medicine (CIIM), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectious Diseases, and Pneumology, University Hospital Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>JHEP Rep</MedlineTA><NlmUniqueID>101761237</NlmUniqueID><ISSNLinking>2589-5559</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-I, angiotensin-converting enzyme inhibitor</Keyword><Keyword MajorTopicYN="N">ACE2, angiotensin-converting enzyme 2</Keyword><Keyword MajorTopicYN="N">ACLF, acute-on-chronic liver failure</Keyword><Keyword MajorTopicYN="N">ALT, alanine aminotransferase</Keyword><Keyword MajorTopicYN="N">AST, aspartate aminotransferase</Keyword><Keyword MajorTopicYN="N">COVID-19, coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">EGD, esophagogastroduodenoscopy</Keyword><Keyword MajorTopicYN="N">ERC, endoscopic retrograde cholangiography</Keyword><Keyword MajorTopicYN="N">HCC, hepatocellular carcinoma</Keyword><Keyword MajorTopicYN="N">MELD, model for end-stage liver disease</Keyword><Keyword MajorTopicYN="N">NAFLD, non-alcoholic fatty liver disease</Keyword><Keyword MajorTopicYN="N">NASH, non-alcoholic steatohepatitis</Keyword><Keyword MajorTopicYN="N">NUC, nucleoside analogue</Keyword><Keyword MajorTopicYN="N">PIs, protease inhibitors</Keyword><Keyword MajorTopicYN="N">RdRp, RNA-dependent RNA polymerase</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2, severe acute respiratory syndrome coronavirus 2</Keyword><Keyword MajorTopicYN="N">ULN, upper limit of normal</Keyword></KeywordList><CoiStatement>Dr Berg reports grants, personal fees and non-financial support from Gilead. Dr Boettler reports consultancy fees from Gilead. Dr Cornberg reports personal fees from Gilead. All other authors report no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32289115</ArticleId><ArticleId IdType="doi">10.1016/j.jhepr.2020.100113</ArticleId><ArticleId IdType="pii">S2589-5559(20)30047-1</ArticleId><ArticleId IdType="pii">100113</ArticleId><ArticleId IdType="pmc">PMC7128473</ArticleId></ArticleIdList><pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Mayo Clin Proc. 2010 May;85(5):451-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20357277</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell. 2020 Mar 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hepatol. 2019 Apr;70(4):797-799</Citation><ArticleIdList><ArticleId IdType="pubmed">30635243</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Drugs. 2017 Apr;77(6):697-704</Citation><ArticleIdList><ArticleId IdType="pubmed">28290136</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Rev Drug Discov. 2020 Mar;19(3):149-150</Citation><ArticleIdList><ArticleId IdType="pubmed">32127666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Oral Sci. 2020 Feb 24;12(1):8</Citation><ArticleIdList><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Respir Med. 2020 Feb 24;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 2013 Apr;57(4):1743-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23357765</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Arthritis Rheumatol. 2017 Sep;69(9):1751-1761</Citation><ArticleIdList><ArticleId IdType="pubmed">28597609</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430</Citation><ArticleIdList><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337</Citation><ArticleIdList><ArticleId IdType="pubmed">32087098</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2020 Mar 12;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation><ArticleIdList><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Trials. 2019 Aug 14;20(1):501</Citation><ArticleIdList><ArticleId IdType="pubmed">31412955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Drug Discov Ther. 2020;14(1):58-60</Citation><ArticleIdList><ArticleId IdType="pubmed">32147628</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 2020 Mar 3;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32125362</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>HIV Clin Trials. 2011 Sep-Oct;12(5):235-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22180521</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation><ArticleIdList><ArticleId IdType="pubmed">32032529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Life Sci. 2020 May 1;248:117477</Citation><ArticleIdList><ArticleId IdType="pubmed">32119961</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):929-936</Citation><ArticleIdList><ArticleId IdType="pubmed">32004427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gastroenterology. 2020 Mar 3;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32142785</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776</Citation><ArticleIdList><ArticleId IdType="pubmed">32054787</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 2020 Mar 27;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32219428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hosp Infect. 2020 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32201338</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hepatol. 2016 Nov;65(5):899-905</Citation><ArticleIdList><ArticleId IdType="pubmed">27388923</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMC Infect Dis. 2020 Jan 28;20(1):80</Citation><ArticleIdList><ArticleId IdType="pubmed">31992207</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Hepatol. 2014 Dec;61(6):1385-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25135860</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2016 Mar 17;531(7594):381-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26934220</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Transplant. 2020 Mar 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32181990</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Commun. 2020 Jan 10;11(1):222</Citation><ArticleIdList><ArticleId IdType="pubmed">31924756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Liver Int. 2020 Mar 14;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32170806</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Cell. 2020 Mar 4;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Mar 18;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Rheum Dis. 2017 Jul;20(7):859-869</Citation><ArticleIdList><ArticleId IdType="pubmed">28160426</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 20;43(0):E019</Citation><ArticleIdList><ArticleId IdType="pubmed">32075365</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Biotechnol. 2020 Apr;38(4):379-381</Citation><ArticleIdList><ArticleId IdType="pubmed">32205870</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Pharmacol Res Perspect. 2017 Jan 23;5(1):e00293</Citation><ArticleIdList><ArticleId IdType="pubmed">28596841</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Mar 11;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32160451</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000167 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000167 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:32289115
|texte= Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32289115" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |